Gene: FEM1B
Official Full Name: fem-1 homolog Bprovided by HGNC
Gene Summary: This gene encodes an ankyrin repeat protein that belongs to the death receptor-associated family of proteins and plays a role in mediating apoptosis. The encoded protein is also thought to function in the replication stress-induced checkpoint signaling pathway via interaction with checkpoint kinase 1. [provided by RefSeq, Aug 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32276 | FEM1B Knockout cell line (HeLa) | Human | FEM1B | 1:3~1:6 | Negative | Online Inquiry |
KO32277 | FEM1B Knockout cell line (HCT 116) | Human | FEM1B | 1:2~1:4 | Negative | Online Inquiry |
KO32278 | FEM1B Knockout cell line (HEK293) | Human | FEM1B | 1:3~1:6 | Negative | Online Inquiry |
KO32279 | FEM1B Knockout cell line (A549) | Human | FEM1B | 1:3~1:4 | Negative | Online Inquiry |
FEM1B Gene Knockout Cell Lines are engineered cellular models specifically designed to disrupt the function of the FEM1B gene, allowing researchers to study its role in various biological processes. These knockout cell lines are critical tools in molecular biology and genetics that facilitate the investigation of gene function, interactions, and pathways associated with the FEM1B protein.
The key function of FEM1B Gene Knockout Cell Lines lies in their ability to provide a system for observing the phenotypic alterations that occur when FEM1B is deleted or rendered inactive. This is achieved through CRISPR-Cas9 gene editing technology, which precisely targets and eliminates the FEM1B gene, creating a model that mimics loss-of-function scenarios. Researchers can analyze downstream effects on cellular processes such as apoptosis, proliferation, and differentiation, which are pivotal in understanding the gene’s role in health and disease.
The scientific significance of FEM1B Gene Knockout Cell Lines is underscored by their application in cancer research, developmental biology, and regenerative medicine. By elucidating the pathways influenced by FEM1B, these cell lines can contribute to the identification of novel therapeutic targets and biomarkers for diseases, including various cancers and genetic disorders.
Compared to traditional knockout methods or wild-type cell lines, FEM1B Gene Knockout Cell Lines offer enhanced specificity and reproducibility, allowing for more nuanced studies. Their high efficiency and user-friendly protocols enable researchers to obtain consistent results, thereby reducing experimental variability. Furthermore, these cell lines are compatible with high-throughput screening, which accelerates the pace of discovery.
For researchers and clinicians, the value of FEM1B Gene Knockout Cell Lines is evident in their potential to unravel disease mechanisms, inform therapeutic approaches, and advance scientific knowledge in a rapidly evolving field. This product is an essential asset for laboratories focused on gene function and the exploration of complex biological questions.
At [Your Company Name], we pride ourselves on our commitment to excellence in biological products. Our expertise in developing advanced genetic models ensures that you receive not only a high-quality product but also essential support for your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.